Professor Cheng Lan's Experience in Treating Endometriosis
article
OA: closed
CC0
AI-generated summary
Professor Cheng treats endometriosis, characterized by dysmenorrhea and infertility, by addressing blood stasis and Yin-Yang deficiency through middle burner regulation and specific decoctions like Xuefu Zhuyu and Jingui Wenjing.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is one of the refractory and common disease in gynaecology, which the main
\nmanifestations are dysmenorrhea and infertility. Professor Cheng considers it's the deficiencyexcess
\nmixing illness whose pathological base is blood stasis and root is the deficiency of Yin
\nand Yang, Qi and blood. So in terms of treatment, Professor Cheng praises highly the way
\nof strengthening the body resistance to eliminate pathogenic factors. Strengthening the body
\nresistance and expelling evil at the same time can achieve the purpose of treatment. In the
\nadjustment of Yin and Yang ,Qi and blood, Professor Cheng attaches importance to treating
\nmiddle burner. On the treatment of dysmenorrhea, Professor Cheng is able to capture xuefu
\nzhuyu decoction and bazhen decoction and pays attention to menstrual cycle therapy. In
\naddition, Professor Cheng often uses jingui wenjing decoction for infertility and re-understands
\nthe decoction by meridians theory and circular motion theory. Furthermore, Professor Cheng’s
\ntreatment in reserving follicle, promoting ovulation and developing follicle is distinctive by
\ntraditional Chinese medicine.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK